Cited by 268Lipoproteins and Cardiovascular HealthCholesterol and Lipid MetabolismParaoxonase enzyme and polymorphisms

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Value of High-Density Lipoprotein (HDL) Subpopulations in Predicting Recurrent Cardiovascular Events in the Veterans Affairs HDL Intervention Trial

Asztalos, Bela F., Collins, Dorothea, Cupples, L. Adrienne, Demissie, Serkalem, Horvath, Katalin V., Bloomfield, Hanna E., Robins, Sander J., Schaefer, Ernst J.·2005·Arteriosclerosis, Thrombosis, and Vascular Biology

DOI 10.1161/01.atv.0000183727.90611.4f

Open this paper in CoChat — free account

Abstract

Objective— To test the hypothesis whether determination of high-density lipoprotein (HDL) subpopulations provides more power to predict recurrent cardiovascular disease (CVD) events (nonfatal myocardial infarction, coronary heart disease death, and stroke) than traditional risk factors in the Veterans Affairs HDL Intervention Trial (VA-HIT). Methods and Results— Apolipoprotein A-I (apoA-I)–containing HDL subpopulations were quantitatively determined by nondenaturing 2D gel electrophoresis. Hazard ratios of recurrent CVD events were calculated by comparing VA-HIT subjects with (n=398) and without (n=1097) such events. Subjects with new CVD events had significantly lower HDL-C, apoA-I, and large cholesterol-rich HDL particle (α-1, α-2, pre–α-1, and pre–α-2) levels, significantly higher triglyceride, and small poorly lipidated HDL particle (pre–β-1 and α-3) levels than subjects without such events. Multivariate analyses indicated that α-1 and α-2 particle levels were significant negative risk factors, whereas α-3 level was a significant positive risk factor for new CVD events. Pre–β-1 level was a significant risk factor for new CVD events only in univariate analysis. A forward selection model indicated that α-1 was the most significant risk factor for recurrent CVD events among HDL particles. Conclusions— An altered HDL subpopulation profile marked with low α-1 and α-2 levels and a high α-3 level in coronary heart disease patients indicated an elevated risk for new CVD events. Moreover, α-1 and α-2 levels were superior to HDL-C levels in risk assessment in patients with low HDL-C in VA-HIT.

Integrity signals

Registry

Crossref · 10.1161/01.atv.0000183727.90611.4f

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Self-citation
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.
(2002) · Circulation · doi:10.1161/circ.106.25.3143 · Cited by 14,092
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary Syndromes: A Randomized Controlled Trial
Nissen, S. E., Tsunoda, T., Tuzcu, E. M., Schoenhagen, P., Cooper, C. J., Yasin, M., Eaton, G. M., Lauer, M. A., Sheldon, W. S., Grines, C. L., et al. (2003) · JAMA · doi:10.1001/jama.290.17.2292 · Cited by 1,707
AN INVESTIGATION OF CORONARY HEART DISEASE IN FAMILIES
Kannel, W. B., Feinleib, M., McNAMARA, P. M., Garrison, R. J., & Castelli, W. P. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112813 · Cited by 1,639
Molecular physiology of reverse cholesterol transport.
Fielding, C. J., & Fielding, P. E. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39898-9 · Cited by 1,448
A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.
Stampfer, M. J., Sacks, F. M., Salvini, S., Willett, W. C., & Hennekens, C. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108083250601 · Cited by 1,163
The Framingham Offspring Study
Allhoff, P., Laaser, U., & Heinrich, J. (1991) · Springer eBooks · doi:10.1007/978-3-642-95642-3_25 · Cited by 832
High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport
Assmann, G., Schulte, H., von Eckardstein, A., & Huang, Y. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05852-2 · Cited by 700
Early incorporation of cell-derived cholesterol into pre-.beta.-migrating high-density lipoprotein
Castro, G. R., & Fielding, C. J. (1988) · Biochemistry · doi:10.1021/bi00401a005 · Cited by 641

Show all 35 references

Research works printed but not linked: 5

10.1161/atvb.17.1.107 · DOI
10.1161/circ.90.2.8044946 · DOI
10.1161/circ.85.1.1728453 · DOI
10.1161/atvb.20.12.2670 · DOI
1998, Eur Heart J, 19, 31

Sorted by citations

Items 101–200 of 268

Historical milestones in measurement of HDL-cholesterol: Impact on clinical and laboratory practice
Langlois, M. R., & Blaton, V. H. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.01.031 · Cited by 34
The effects of ezetimibe and orlistat, alone or in combination, on high-density lipoprotein (HDL) subclasses and HDL-associated enzyme activities in overweight and obese patients with hyperlipidaemia
Nakou, E., Filippatos, T. D., Kiortsis, D. N., Derdemezis, C. S., Tselepis, A. D., Mikhailidis, D. P., & Elisaf, M. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560802548430 · Cited by 35
An evaluation of RVX-208 for the treatment of atherosclerosis
Nikolić, D., Rizzo, M., Mikhailidis, D. P., Wong, N. C. W., & Banach, M. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.1083010 · Cited by 36
Effects of cholesteryl ester transfer protein inhibitors on human lipoprotein metabolism
Schaefer, E. J. (2013) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283612454 · Cited by 34
Self-citation
Apoprotein B, Small‐Dense LDL and Impaired HDL Remodeling Is Associated With Larger Plaque Burden and More Noncalcified Plaque as Assessed by Coronary CT Angiography and Intravascular Ultrasound With Radiofrequency Backscatter: Results From the ATLANTA I Study
Vörös, S., Joshi, P. H., Qian, Z., Rinehart, S. J., Figueroa, J. G. V., Anderson, H., Elashoff, M. R., Murrieta, L., Karmpaliotis, D., Kalynych, A. M., et al. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000344 · Cited by 34
Self-citation
High-Density Lipoprotein Metabolism and Function in Cardiovascular Diseases: What about Aging and Diet Effects?
Morvaridzadeh, M., Zoubdane, N., Heshmati, J., Alami, M., Berrougui, H., & Khalil, A. (2024) · Nutrients · doi:10.3390/nu16050653 · Cited by 39
Dose-dependent Effect of Rosuvastatin Treatment on HDL-subfraction Phenotype in Patients With Primary Hyperlipidemia
Kostapanos, M. S., Milionis, H. J., Filippatos, T. D., Christogiannis, L. G., Bairaktari, E. T., Tselepis, A. D., & Elisaf, M. (2009) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248408331031 · Cited by 30
High-Density Lipoprotein Subfractions: Much Ado about Nothing or Clinically Important?
Lappegård, K. T., Kjellmo, C. A., & Hovland, A. (2021) · Biomedicines · doi:10.3390/biomedicines9070836 · Cited by 30
Serum cholesterol and triglyceride reference ranges of twenty lipoprotein subclasses for healthy Japanese men and women
Furusyo, N., Ai, M., Okazaki, M., Ikezaki, H., Ihara, T., Hayashi, T., Hiramine, S., Ura, K., Kohzuma, T., Schaefer, E. J., et al. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.09.008 · Cited by 30
Self-citation
Computational Lipidology: Predicting Lipoprotein Density Profiles in Human Blood Plasma
Hübner, K., Schwager, T., Winkler, K., Jg, R., & Holzhütter, H. (2008) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000079 · Cited by 30
Pioglitazone improves the cardiovascular profile in patients with uncomplicated systemic lupus erythematosus: a double-blind randomized clinical trial
Juárez-Rojas, J. G., Medina-Urrutia, A. X., Galarza, E. J., Caracas-Portilla, N., Posadas‐Sánchez, R., Cardoso-Saldaña, G. C., Goycochea-Robles, M., Silveira, L., Lino-Pérez, L., Mas‐Oliva, J., et al. (2011) · Lupus · doi:10.1177/0961203311422096 · Cited by 29
High-density lipoproteins are abnormal in young women with uncomplicated systemic lupus erythematosus
Juárez-Rojas, J. G., Medina-Urrutia, A. X., Posadas‐Sánchez, R., Galarza, E. J., Mendoza-Peŕez, E., Caracas-Portilla, N., Cardoso-Saldaña, G. C., Muñoz-Gallegos, G., & Posadas‐Romero, C. (2008) · Lupus · doi:10.1177/0961203308093072 · Cited by 29
Effects of raloxifene on lipid and lipoprotein levels in postmenopausal osteoporotic women with and without hypertriglyceridemia
Dayspring, T. D., Qu, Y., & Keech, C. A. (2006) · Metabolism · doi:10.1016/j.metabol.2006.03.005 · Cited by 29
HDL abnormalities in type 2 diabetes: Clinical implications
Martagón, A. J., Zubirán, R., González-Arellanes, R., Praget-Bracamontes, S., Rivera-Alcántara, J. A., & Aguilar-Salinas, C. A. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.117213 · Cited by 30
High-density lipoproteins: Marker of cardiovascular risk and therapeutic target
Toth, P. P., & Davidson, M. H. (2010) · Journal of clinical lipidology · doi:10.1016/j.jacl.2010.08.002 · Cited by 28
Epistatic Effect of Cholesteryl Ester Transfer Protein and Hepatic Lipase on Serum High-Density Lipoprotein Cholesterol Levels
Isaacs, A. J., Aulchenko, Y. S., Albert Hofman, D., Sijbrands, E. J. G., Sayed‐Tabatabaei, F. A., Klungel, O. H., der Zee, A. H. M., Stricker, B. H. C., Oostra, B. A., Witteman, J. C. M., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0269 · Cited by 28
N-terminal mutation of apoA-I and interaction with ABCA1 reveal mechanisms of nascent HDL biogenesis
Liu, M., Mei, X., Herscovitz, H., & Atkinson, D. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m084376 · Cited by 28
Changes in remnant and high-density lipoproteins associated with hormone therapy and progression of coronary artery disease in postmenopausal women
Lamon‐Fava, S., Herrington, D. M., Reboussin, D. M., Sherman, M., Horvath, K. V., Schaefer, E. J., & Asztalos, B. F. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.12.020 · Cited by 29
Self-citation
High-density lipoproteins for therapeutic delivery systems
Mutharasan, R. K., Foit, L., & Thaxton, C. S. (2015) · Journal of Materials Chemistry B · doi:10.1039/c5tb01332a · Cited by 28
HDL Particle Measurement: Comparison of 5 Methods
Matera, R. M., Horvath, K. V., Nair, H., Schaefer, E. J., & Asztalos, B. F. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2017.277632 · Cited by 28
Self-citation
High-density lipoprotein subclasses distribution and composition in Mexican adolescents with low HDL cholesterol and/or high triglyceride concentrations, and its association with insulin and c-reactive protein
Medina-Urrutia, A. X., Juárez-Rojas, J. G., Martínez-Alvarado, M. R., Galarza, E. J., Posadas‐Sánchez, R., Cardoso-Saldaña, G. C., Caracas-Portilla, N., Mendoza-Peŕez, E., & Posadas‐Romero, C. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.02.029 · Cited by 26
Small High‐Density Lipoprotein (HDL) Subclasses are Increased with Decreased Activity of HDL‐Associated Phospholipase A2 in Subjects with Prediabetes
Filippatos, T. D., Rizos, E. C., Tsimihodimos, V., Gazi, I. F., Tselepis, A. D., & Elisaf, M. (2013) · Lipids · doi:10.1007/s11745-013-3787-1 · Cited by 27
Novel Lipoprotein Subfraction and Size Measurements in Prediction of Mortality in Maintenance Hemodialysis Patients
Noori, N., Caulfield, M. P., Salameh, W. A., Reitz, R. E., Nicholas, S. B., Molnar, M. Z., Nissenson, A. R., Kovesdy, C. P., & Kalantar‐Zadeh, K. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03650411 · Cited by 25
Markers of Systemic Inflammation and Apo-AI Containing HDL Subpopulations in Women with and without Diabetes
Russo, G. T., Giandalia, A., Romeo, E. L., Alibrandi, A., Horvath, K. V., Asztalos, B. F., & Cucinotta, D. (2014) · International Journal of Endocrinology · doi:10.1155/2014/607924 · Cited by 25
Self-citation
Subfractions of high-density lipoprotein (HDL) and dysfunctional HDL in chronic kidney disease patients
Rysz-Górzyńska, M., & Banach, M. (2016) · Archives of Medical Science · doi:10.5114/aoms.2016.60971 · Cited by 25
High-density lipoprotein subclass and particle size in coronary heart disease patients with or without diabetes
Tian, L., Long, S., Li, C., Liu, Y., Chen, Y., Zeng, Z., & Fu, M. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-54 · Cited by 24
Cholesteryl ester transfer protein inhibitors for dyslipidemia: focus on dalcetrapib
Hegele, R. A., & Goldberg (2012) · Drug Design Development and Therapy · doi:10.2147/dddt.s34976 · Cited by 24
Association of R230C ABCA1 gene variant with low HDL-C levels and abnormal HDL subclass distribution in Mexican school-aged children
Flores-Dorantes, M. T., Arellano‐Campos, O., Posadas‐Sánchez, R., Villarreal-Molina, M. T., Medina-Urrutia, A. X., Romero‐Hidalgo, S., Yescas, P., Pérez-Méndez, O. A., Galarza, E. J., Tusié‐Luna, T., et al. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.04.025 · Cited by 22
HDL drug carriers for targeted therapy
Liu, X., Suo, R., Xiong, S.-L., Zhang, Q., & Yi, G. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.10.008 · Cited by 22
Effect of hormone replacement therapy on plasma lipoprotein levels and coronary atherosclerosis progression in postmenopausal women according to type 2 diabetes mellitus status
Lamon‐Fava, S., Herrington, D. M., Horvath, K. V., Schaefer, E. J., & Asztalos, B. F. (2010) · Metabolism · doi:10.1016/j.metabol.2010.05.012 · Cited by 22
Self-citation
Effect of fenofibrate therapy and ABCA1 polymorphisms on high-density lipoprotein subclasses in the Genetics of Lipid Lowering Drugs and Diet Network
Tsai, M. Y., Ordovás, J. M., Li, N., Straka, R. J., Hanson, N. Q., Arends, V. L., & Arnett, D. K. (2010) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2010.03.001 · Cited by 22
HDL Dysfunction Caused by Mutations in apoA-I and Other Genes that are Critical for HDL Biogenesis and Remodeling
Chroni, A., & Kardassis, D. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180313114950 · Cited by 23
Benefits and Difficulties in Measuring HDL Subfractions and Human Paraoxonase-1 Activity During Statin Treatment
Harangi, M., Seres, I., Harangi, J., & Paragh, G. (2009) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-009-6205-4 · Cited by 22
In cross-sectional observations, dietary quality is not associated with CVD risk in women; in men the positive association is accounted for by BMI
Wood, A. C., Kim, J., Davis, J. S., Jung, S. Y., & Chang, S. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515000185 · Cited by 23
Of Mice and Men
Watts, G. F., & Chan, D. C. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.175224 · Cited by 22
Short Communication: Effects of Omega-3 Fatty Acids on Triglycerides and High-Density Lipoprotein Subprofiles in HIV-Infected Persons with Hypertriglyceridemia
Paranandi, A., Asztalos, B. F., Mangili, A., Kuvin, J., Gerrior, J., Sheehan, H. B., Skinner, S. C., Tang, A., & WANKE, C. A. (2014) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2014.0005 · Cited by 21
Self-citation
Essential Fatty Acid and Prostaglandin Metabolism in Sjögren’s Syndrome, Systemic Sclerosis and Rheumatoid Arthritis
Horrobin, D. F. (1986) · Scandinavian Journal of Rheumatology · doi:10.1080/15027732.1986.12461420 · Cited by 21
High Density Lipoprotein Particle Composition, Functionality, Deficiency, and Atherosclerotic Cardiovascular Disease Risk: A Review
Schaefer, E. J., Asztalos, B. F., Vaisar, T., Diffenderfer, M. R., Brewer, H. B., Stock, E. O., & Kane, J. P. (2025) · Current Atherosclerosis Reports · doi:10.1007/s11883-025-01308-9 · Cited by 20
Self-citation
Cystic fibrosis and fat malabsorption: Pathophysiology of the cystic fibrosis gastrointestinal tract and the impact of highly effective CFTR modulator therapy
McDonald, C. M., Reid, E. K., Pohl, J. F., Yuzyuk, T. K., Padula, L., Vavrina, K., & Altman, K. (2024) · Nutrition in Clinical Practice · doi:10.1002/ncp.11122 · Cited by 25
Characteristics of low-density and high-density lipoprotein subclasses in pediatric renal transplant recipients
Zeljković, A., Vekić, J., Spasojević‐Kalimanovska, V., Jelić‐Ivanović, Z., Peco‐Antić, A., Kostic, M., Vasić, D., & Spasić, S. (2011) · Transplant International · doi:10.1111/j.1432-2277.2011.01313.x · Cited by 19
New and Emerging Biomarkers in Cardiovascular Disease
Cahill, L. E., Bertoia, M. L., Aroner, S. A., Mukamal, K. J., & Jensen, M. K. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0661-y · Cited by 20
Distinct effects of fixed combinations of valsartan with either amlodipine or hydrochlorothiazide on lipoprotein subfraction profile in patients with hypertension
Christogiannis, L. G., Kostapanos, M. S., Tellis, C. C., Milionis, H. J., Tselepis, A. D., & Elisaf, M. (2011) · Journal of Human Hypertension · doi:10.1038/jhh.2011.108 · Cited by 19
Human serum preβ1-high density lipoprotein levels are independently and negatively associated with coronary artery diseases
Chen, Y., Dong, J., Chen, X., Jiang, H., Bakillah, A., Zhang, X., Li, Z., Yin, J., Liang, D., Zou, Y., et al. (2016) · Nutrition & Metabolism · doi:10.1186/s12986-016-0093-y · Cited by 19
Levels of prebeta-1 high-density lipoprotein are elevated in 3 phenotypes of dyslipidemia
Stock, E. O., Ferrara, C. T., O'Connor, P. M., Naya-Vigne, J. M., Frost, P. H., Malloy, M. J., Kane, J. P., & Pullinger, C. R. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.11.001 · Cited by 20
Effects of cholesteryl ester transfer protein inhibition on apolipoprotein A-II-containing HDL subspecies and apolipoprotein A-II metabolism
Brousseau, M. E., Millar, J. S., Diffenderfer, M. R., Nartsupha, C., Asztalos, B. F., Wolfe, M. L., Mancuso, J. P., DIGENIO, A. G., Rader, D. J., & Schaefer, E. J. (2009) · Journal of Lipid Research · doi:10.1194/jlr.p800037-jlr200 · Cited by 20
Self-citation
Carotid intima media thickness is related positively to plasma pre ß-high density lipoproteins in non-diabetic subjects
de Vries, R., Perton, F. G., van Tol, A., & Dullaart, R. P. F. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.11.001 · Cited by 18
Alterations of high-density lipoprotein subclasses in hypercholesterolemia and combined hyperlipidemia
Jia, L., Fu, M., Tian, Y., Xu, Y., Gou, L., Tian, H., & Tian, L. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.10.007 · Cited by 18
Associations of Genetic Variants in ATP-Binding Cassette A1 and Cholesteryl Ester Transfer Protein and Differences in Lipoprotein Subclasses in the Multi-Ethnic Study of Atherosclerosis
Tsai, M. Y., Li, N., Sharrett, A. R., Shea, S., Jacobs, D. R., Tracy, R. P., Arnett, D. K., Arends, V. L., & Post, W. S. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.107995 · Cited by 18
HDL Is Not Dead Yet
Lorkowski, S. W., & Smith, J. D. (2022) · Biomedicines · doi:10.3390/biomedicines10010128 · Cited by 18
Relationships between HDL subpopulation proteome and HDL function in overweight/obese people with and without coronary heart disease
Vaisar, T., Babenko, I., Horvath, K. V., Niisuke, K., & Asztalos, B. F. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.118565 · Cited by 17
Self-citation
Apolipoproteins and long-term prognosis in coronary heart disease patients
Benderly, M., Boyko, V., & Goldbourt, U. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.08.008 · Cited by 17
An apoA-I mimetic peptibody generates HDL-like particles and increases alpha-1 HDL subfraction in mice
Lu, S.-C., Atangan, L. I., Kim, K. W., Chen, M. M., Komorowski, R., Chu, C., Han, J., Hu, S., Gu, W., Véniant, M. M., et al. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m020438 · Cited by 17
Plasma pre β-HDL formation is decreased by atorvastatin treatment in type 2 diabetes mellitus: Role of phospholipid transfer protein
Dallinga‐Thie, G. M., van Tol, A., & Dullaart, R. P. F. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.03.008 · Cited by 17
A Translational Medicine perspective of the development of torcetrapib: Does the failure of torcetrapib development cast a shadow on future development of lipid modifying agents, HDL elevation strategies or CETP as a viable molecular target for atherosclerosis? A case study of the use of biomarkers and Translational Medicine in atherosclerosis drug discovery and development
Zhao, L., Jin, W., Rader, D. J., Packard, C. J., & Feuerstein, G. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.03.014 · Cited by 17
High density lipoprotein modulates osteocalcin expression in circulating monocytes: a potential protective mechanism for cardiovascular disease in type 1 diabetes
Maddaloni, E., Xia, Y., Park, K., D’Eon, S., TINSLEY, L. J., St-Louis, R., Khamaisi, M., Li, Q., King, G. L., & Keenan, H. A. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0599-2 · Cited by 17
The improvement of large High-Density Lipoprotein (HDL) particle levels, and presumably HDL metabolism, depend on effects of low-carbohydrate diet and weight loss
Finelli, C., Crispino, P., Gioia, S., Sala, N. L., D'Amico, L., Grotta, M. L., Miro, O., & Colarusso, D. (2016) · EXCLI journal · doi:10.17179/excli2015-642 · Cited by 16
Retracted
Native–Native 2D Gel Electrophoresis for HDL Subpopulation Analysis
Freeman, L. A. (2013) · Methods in molecular biology · doi:10.1007/978-1-60327-369-5_17 · Cited by 16
Effects of weight change on HDL-cholesterol and its subfractions in over 28,000 men and women
Dansinger, M. L., Williams, P. T., Superko, H. R., Asztalos, B. F., & Schaefer, E. J. (2018) · Journal of clinical lipidology · doi:10.1016/j.jacl.2018.12.001 · Cited by 16
Self-citation
Glycemic control and high-density lipoprotein characteristics in adolescents with type 1 diabetes
Medina‐Bravo, P., Medina-Urrutia, A. X., Juárez-Rojas, J. G., Cardoso-Saldaña, G. C., Galarza, E. J., Posadas‐Sánchez, R., Coyote-Estrada, N., Nishimura‐Meguro, E., & Posadas‐Romero, C. (2012) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2012.00924.x · Cited by 16
Levels of Prebeta‐1 High‐Density Lipoprotein Are a Strong Independent Positive Risk Factor for Coronary Heart Disease and Myocardial Infarction: A Meta‐Analysis
Pullinger, C. R., O’Connor, P. M., Naya-Vigne, J. M., Kunitake, S. T., Movsesyan, I., Frost, P. H., Malloy, M. J., & Kane, J. P. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.018381 · Cited by 15
The influence of apoE-deficiency and LDL-receptor-deficiency on the HDL subpopulation profile in mice and in humans
Tani, M., Matera, R. M., Horvath, K. V., Hasan, T. S., Schaefer, E. J., & Asztalos, B. F. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.11.080 · Cited by 15
Self-citation
Evacetrapib reduces preβ-1 HDL in patients with atherosclerotic cardiovascular disease or diabetes
Chen, Y., Dong, J., Zhang, X., Chen, X., Wang, L., Chen, H., Ge, J., & Jiang, X. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.04.211 · Cited by 16
Relationship between plasma apolipoproteinB concentrations, apolipoproteinB/apolipoproeinA-I and HDL subclasses distribution
Tian, L., Wu, X., Fu, M., Qin, Y., Xu, Y., & Jia, L. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.10.028 · Cited by 15
Plasma triglyceride levels and body mass index values are the most important determinants of preβ-1 HDL concentrations in patients with various types of primary dyslipidemia
Tsimihodimos, V., Gazi, I. F., Filippatos, T. D., Kostapanos, M. S., Lagos, K., Kostara, C. E., Tellis, C. C., Elisaf, M., & Tselepis, A. D. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.07.038 · Cited by 14
The association between dyslipidemia and anthropometric indicators in black and white adolescents residing in Tlokwe Municipality, North-West Province, South Africa: the PAHL study
Mamabolo, R., Sparks, M., Moss, S. J., & Monyeki, M. A. (2015) · African Health Sciences · doi:10.4314/ahs.v14i4.23 · Cited by 14
Where are we with high-density lipoprotein raising and inhibition of cholesteryl ester transfer for heart disease risk reduction?
Schaefer, E. J., & Asztalos, B. F. (2007) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3281fbd3c7 · Cited by 14
Self-citation
Anacetrapib: Hope for CETP Inhibitors?
Gurfinkel, R., & JOY, T. R. (2010) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2010.00142.x · Cited by 13
Overexpression of stearoyl-coenzyme A desaturase 1 in macrophages promotes reverse cholesterol transport
Nakaya, K., Ayaori, M., Uto‐Kondo, H., Sotherden, G. M., Nishida, T., Katamoto, H., Miura, Y., Takiguchi, S., Yakushiji, E., Iizuka, M., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.05.009 · Cited by 13
Abnormal High-Density Lipoproteins in Overweight Adolescents With Atherogenic Dyslipidemia
Medina-Urrutia, A. X., Juárez-Rojas, J. G., Cardoso-Saldaña, G. C., Galarza, E. J., Posadas‐Sánchez, R., Martínez-Alvarado, M. R., Caracas-Portilla, N., Mendoza-Peŕez, E., & Posadas‐Romero, C. (2011) · PEDIATRICS · doi:10.1542/peds.2010-1395 · Cited by 13
High-density lipoprotein cholesterol
Oda, M. N. (2015) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000139 · Cited by 14
Clinical Trials Update AHA Congress 2010
Horowitz, J. D., Rosenson, R. S., McMurray, J. J. V., Marx, N., & Remme, W. J. (2011) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-011-6285-9 · Cited by 11
High-density lipoprotein particles, coronary heart disease, and niacin
Asztalos, B. F. (2010) · Journal of clinical lipidology · doi:10.1016/j.jacl.2010.08.012 · Cited by 11
Self-citation
Ruminant-Produced trans-Fatty Acids Raise Plasma HDL Particle Concentrations in Intact and Ovariectomized Female Hartley Guinea Pigs
Rice, B. H., Kraft, J., Destaillats, F., Bauman, D. E., & Lock, A. L. (2012) · Journal of Nutrition · doi:10.3945/jn.112.160077 · Cited by 11
High-density lipoprotein: our elusive friend
Asztalos, B. F., Niisuke, K., & Horvath, K. V. (2019) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000612 · Cited by 11
Self-citation
The interplay between lipoprotein phenotypes, adiponectin, and alcohol consumption
Kuusisto, S. M., Peltola, T., Laitinen, M., Kumpula, L. S., Mäkinen, V., Salonurmi, T., Hedberg, P. S. M., Jauhiainen, M., Savolainen, M. J., Hannuksela, M. L., et al. (2011) · Annals of Medicine · doi:10.3109/07853890.2011.611529 · Cited by 10
Total HDL cholesterol efflux capacity in healthy children – Associations with adiposity and dietary intakes of mother and child
Khalil, H. S., Murrin, C. M., O'Reilly, M. E., Viljoen, K., Segurado, R., O’Brien, J., Somerville, R. L., McGillicuddy, F. C., & Kelleher, C. (2016) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.10.002 · Cited by 10
Elevated levels of preβ1-high-density lipoprotein are associated with cholesterol ester transfer protein, the presence and severity of coronary artery disease
Bu, X., Niu, D.-M., Wu, J., Yuan, Y., Song, J., & Wang, J. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-016-0394-1 · Cited by 10
Cardiovascular Risk Factor Reduction in First Responders Resulting From an Individualized Lifestyle and Blood Test Program
Gill, R. D., Superko, H. R., McCarthy, M. M., Jack, K., Jones, B., Ghosh, D., Richards, S., Gleason, J. A., Williams, P. T., & Dansinger, M. L. (2018) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000001490 · Cited by 10
Arylesterase activity of paraoxonase 1 (PON1) on HDL3 and HDL2: Relationship with Q192R, C-108T, and L55M polymorphisms
Valencia, S., Mejia, C. A. I., Bonilla, J. H., Beltrán, L., Loango, N., & Landázuri, P. (2021) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2021.100971 · Cited by 10
The relationship between physical activity and lipoprotein subclasses in postmenopausal women
Gabriel, K. P., Kriska, A. M., Johnson, B. D., Conroy, M. B., Mackey, R. H., Orchard, T. J., & Kuller, L. H. (2006) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000229573.29258.d5 · Cited by 10
Metformin Increases HDL3–Cholesterol and Decreases Subcutaneous Truncal Fat in Nondiabetic Patients with HIV-Associated Lipodystrophy
DIEHL, L. A., Fabris, B. A., Barbosa, D. S., de Faria, E. C., Wiechmann, S. L., & Carrilho, A. J. F. (2008) · AIDS Patient Care and STDs · doi:10.1089/apc.2008.0012 · Cited by 10
Moderate statin treatment reduces prebeta-1 high-density lipoprotein levels in dyslipidemic patients
Quinn, A., Schwemberger, R., Stock, E. O., Movsesyan, I., Axtell, A. L., Chang, S. L., Ishida, B. Y., Malloy, M. J., Kane, J. P., & Pullinger, C. R. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.04.118 · Cited by 10
Low plasma HDL‐c, a vascular risk factor in high risk patients independent of LDL‐c
Hajer, G. R., van der Graaf, Y., Bots, M. L., Algra, A., Visseren, F. L. J., & on behalf of the SMART Study Group (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02155.x · Cited by 10
Synthetic HDL as a new treatment for atherosclerosis regression: Has the time come?
Conca, P., & Franceschini, G. (2008) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.11.001 · Cited by 10
The relationship between high density lipoprotein subclass profile and apolipoprotein concentrations
Tian, L., & Fu, M. (2011) · Journal of Endocrinological Investigation · doi:10.1007/bf03346714 · Cited by 9
Más allá de los parámetros lipídicos tradicionales en la enfermedad renal crónica
Bermúdez-López, M., Betriu, À., Valdivielso, J. M., del Pino, T. B., Arroyo, D., & Fernández, E. (2017) · Nefrología · doi:10.1016/j.nefro.2017.09.008 · Cited by 9
Effects of fatty liver on the size and composition of high‐density lipoprotein cholesterol subpopulations in adolescents with type 2 diabetes mellitus
Morales, J. A. O., Urrutia, A. X. M., Torres‐Tamayo, M., Galarza, E. J., Barrera, J. R., Suárez, P. D., Juárez-Rojas, J. G., & Medina‐Bravo, P. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13103 · Cited by 9
High-Density Lipoprotein Particles, Inflammation, and Coronary Heart Disease Risk
Stock, E. O., Asztalos, B. F., Miller, J. M., He, L., Creasy, K. T., Schwemberger, R., Quinn, A. T., Pullinger, C. R., Malloy, M. J., Diffenderfer, M. R., et al. (2025) · Nutrients · doi:10.3390/nu17071182 · Cited by 9
Self-citation
Lipoprotein Metabolism and the Treatment of Lipid Disorders
Freeman, M. W., & Walford, G. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00041-x · Cited by 10
The effect of weight loss on HDL subfractions and LCAT activity in two genotypes of APOA-II -265T>C polymorphism
Moradi, M., Mahmoudi, M., Saedisomeolia, A., Zahirihashemi, R., & Koohdani, F. (2017) · Nutrition Journal · doi:10.1186/s12937-017-0255-4 · Cited by 8
Combining Rosuvastatin With Angiotensin-Receptor Blockers of Different PPARγ-Activating Capacity
Rizos, C. V., Liberopoulos, E. N., Tellis, K., DiNicolantonio, J. J., Tselepis, A. D., & Elisaf, M. (2013) · Angiology · doi:10.1177/0003319713512556 · Cited by 8
Functionality of HDL particles: Heterogeneity and relationships to cardiovascular disease
Camont, L., Chapman, J., & Kontush, A. (2011) · Archives of Cardiovascular Diseases Supplements · doi:10.1016/s1878-6480(11)70784-4 · Cited by 8
High-density lipoprotein: what is the best way to measure its antiatherogenic potential?
Remaley, A. T., & Warnick, G. R. (2008) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2.7.773 · Cited by 8
High-density Lipoprotein
Merkel, M. (2012) · Der Diabetologe · doi:10.1007/s11428-012-0889-y · Cited by 8
Effects of heavy alcohol intake on lipoproteins, adiponectin and cardiovascular risk
Kuusisto, S. M. (2014) · Cited by 7
The PPAR pan-agonist tetradecylthioacetic acid promotes redistribution of plasma cholesterol towards large HDL
Lundåsen, T., Pedrelli, M., Bjørndal, B., Rozell, B., Kuiper, R., Burri, L., Pavanello, C., Turri, M., Skorve, J., Berge, R. K., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0229322 · Cited by 7
Separation of the principal HDL subclasses by iodixanol ultracentrifugation
Harman, N., Griffin, B. A., & Davies, I. G. (2013) · Journal of Lipid Research · doi:10.1194/jlr.d037432 · Cited by 7
Where next with HDL assays?
Niisuke, K., Horvath, K. V., & Asztalos, B. F. (2018) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000529 · Cited by 7
Self-citation
Strategies for the development of new PPAR agonists in diabetes
Cavender, M. A., Nicholls, S. J., & Michael, L. A. (2010) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000368196.17109.5e · Cited by 7
Beyond the traditional lipid parameters in chronic kidney disease
Bermúdez-López, M., Betriu, À., Valdivielso, J. M., del Pino, T. B., Arroyo, D., & Fernández, E. (2017) · Nefrología (English Edition) · doi:10.1016/j.nefroe.2017.11.016 · Cited by 7

Authors: Asztalos, B. F., Collins, D., Cupples, L. A., Demissie, S., Horvath, K. V., Bloomfield, H. E., Robins, S. J., & Schaefer, E. J.
Affiliations: Boston University (US)
ORCID: Asztalos, Bela F.
Cupples, L. Adrienne
Demissie, Serkalem
Bloomfield, Hanna E.
Schaefer, Ernst J.
Venue: Arteriosclerosis, Thrombosis, and Vascular Biology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2005-10
Volume: 25
Issue: 10
Pages: 2185-2191
ISSN: 1079-5642 (ISSN-L)
1524-4636
DOI: 10.1161/01.atv.0000183727.90611.4f
OpenAlex: W2160230170
Cited by: 268
References: 35
Citations by year: 2026: 3 · 2025: 2 · 2024: 4 · 2023: 4 · 2022: 5 · 2021: 4 · 2020: 7 · 2019: 4 · 2018: 12 · 2017: 10 · 2016: 8 · 2015: 12 · 2014: 14 · 2013: 22 · 2012: 17
FWCI: 24.09
Type: journal article
Language: en
Open access: closed
Locations: Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
PubMed (publishedVersion)
Funders: National Heart, Lung, and Blood Institute (HL 64738, R01HL064738)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
Keywords: HDL subpopulations, apolipoprotein A-I, HDL particle size, cardiovascular risk prediction, recurrent cardiovascular events, coronary artery disease, myocardial infarction, stroke, HDL cholesterol, triglycerides, veterans
MeSH terms: Aged, Cardiovascular Diseases, Coronary Disease, Follow-Up Studies, Humans, Lipoproteins, LDL, Male, Middle Aged, Myocardial Infarction, Predictive Value of Tests, Recurrence, Risk Factors, United States, United States Department of Veterans Affairs, Biomarkers, Proportional Hazards Models, Stroke

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Value of High-Density Lipoprotein (HDL) Subpopulations in Predicting Recurrent Cardiovascular Events in the Veterans Affairs HDL Intervention Trial

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks